Hepatitis E Virus (HEV) Antibody, IgG
Also known as: HEV IGG
Use
The Hepatitis E Virus (HEV) Antibody, IgG test is used for determining exposure to the Hepatitis E Virus. A positive result suggests that an individual has been exposed to Hepatitis E Virus, as indicated by the presence of IgG antibodies. The test can aid in the diagnosis of HEV infections, thereby informing potential public health responses and individual patient management. It is typically utilized in clinical settings to monitor HEV infection in patients with relevant symptoms or travel histories to endemic areas.
Special Instructions
Specimen collection requires a serum separator tube, and blood should be separated from cells as soon as possible or within 2 hours. Transfer 0.5 mL of serum to an ARUP Standard Transport Tube. The minimum volume required is 0.3 mL. Specimens should be refrigerated during transport. Stability is 2 weeks refrigerated and indefinitely frozen, provided repeated freeze/thaw cycles are avoided.
Limitations
This test has been developed by ARUP Laboratories and its performance characteristics determined under CLIA certification. However, it has not been cleared or approved by the FDA, and the test is intended solely for clinical use. Specimens containing particulate material are unacceptable, which could lead to rejection of the sample.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 14211-7
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.3 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate from cells as soon as possible or within 2 hours of collection. Transfer 0.5 mL serum to an ARUP Standard Transport Tube.
Causes for Rejection
Specimens containing particulate material
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 2 weeks |
| Frozen | Indefinitely (avoid repeated freeze/thaw cycles) |